284663-03-2

Upstream product

• 1125-88-8 benzaldehyde dimethyl acetal 
• 284663-20-3 Pent-4-enyl 3'-O-benzyl-β-D-lactoside 
• 153228-87-6 n-pentenyl (β-D-galactopyranosyl)-(1<*>4)-β-D-glucopyranoside 
• 4753-07-5 2,3,6,2',3',4',6'-hepta-O-acetyl-lactosyl bromide 
• 3616-19-1 1',2',3',6',2,3,4,6-octa-O-acetyl-β-D-lactose 
• 256426-90-1 Peracetyl pent-4-enyl β-D-lactoside 

Downstream Products

• 284663-21-4 (2S,4aR,6S,7R,8S,8aS)-7,8-Bis-benzyloxy-6-((2R,3R,4S,5R,6R)-4,5-bis-benzyloxy-2-benzyloxymethyl-6-pent-4-enyloxy-tetrahydro-pyran-3-yloxy)-2-phenyl-hexahydro-pyrano[3,2-d][1,3]dioxine 
• 284663-04-3 Pent-4-enyl 2,2',3,3',6,6'-hexa-O-benzyl-β-D-lactoside 

Relevant academic research and scientific papers

A second generation synthesis of the MBr1 (Globo-H) breast tumor antigen: New application of the n-pentenyl glycoside method for achieving complex carbohydrate protein linkages

A new synthesis of the hexasaccharide MBr1 antigen (globo-H) is reported. A revised construction with improved efficiency was necessary because an anti-cancer vaccine containing this antigen is entering phase II and phase III clinical trials for prostate